Propranolol does not affect incidence of spontaneous bacterial peritonitis in cirrhotic patients with ascites [8]

American Journal of Gastroenterology

Volumn 98, Issue 6, 2003, Pages 1446-1448

  Soylu, Ali Riza ^a,b   Dökmeci, Gülbin ^a   Tezel, Ahmet ^a   Amuca, Hümeyra ^a   Ümit, Hasan ^a  

^a Faculty of Economics and Administrative Sciences   (Turkey)

^b TRAKYA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; FUROSEMIDE; PROPRANOLOL; SPIRONOLACTONE;

ADULT; AGED; ASCITES; BACTERIAL PERITONITIS; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; DRUG MECHANISM; ESCHERICHIA COLI; FEMALE; HUMAN; INCIDENCE; LETTER; LIVER CIRRHOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS;

EID: 0037635177     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07507.x     Document Type: Letter

References (12)

1. Runyon BA. Ascites and spontaneous bacterial peritonitis. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Gastrointestinal and liver disease: Pathophysiology, diagnosis and management. Philadelphia: W.B. Saunders, 1998:1310-33.
2. Perez-Paramo M, Munoz J, Albillos A, et al. Effect of propranolol on factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 2000;31:43-8.
3. Hoshino S, Shinoura S, Akamine H, et al. Effect of propranolol for the prevention of spontaneous bacterial peritonitis. Am J Gastroenterol 2000;349:A2513 (abstract).
4. Ramachandran A, Balasubramanian KA. Intestinal dysfunction in liver cirrhosis: Its role in spontaneous bacterial peritonitis. J Gastroenterol Hepatol 2001;16:607-12.
5. Chang CS, Yang SS, Kao CH, et al. Small intestinal bacterial overgrowth versus antimicrobial capacity in patients with spontaneous bacterial peritonitis. Scand J Gastroenterol 2001; 36:92-6.
6. Guarner C, Runyon BA, Young S, et al. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatology 1997;26:1372-8.
7. Garcia-Tsao G, Albillos A, Barden GE, et al. Bacterial translocation in acute and chronic portal hypertension. Hepatology 1993;17:1081-5.
8. Livolet JM, Bartoli R, March F, et al. Translated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: Molecular epidemiologic evidence. J Hepatol 1998;28: 307-13.
9. Reilly JA, Quigley EMM, Forst CF, Rikkers LF. Small intestinal transit in the portal hypertensive rat. Gastroenterology 1991;100:670-4.
10. McIntyre AS, Thompson DG, Burnham WR, Walker ER. Modulation of human upper intestinal nutrient transit by a beta-adrenoceptor mediated pathway. Gut 1992;33:1062-70.
11. Ahluwalia NK, Thompson DG, Barlow J, Heggie L. Betaadrenergic modulation of human upper intestinal propulsive forces. Gut 1994;35:1356-9.
12. Bartoli R, Pardo A, Lorenzo-Zuniga V, et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 2000;31:858-63.